Clinical trial
Effects of Pitavastatin on Insulin Sensitivity and Liver Fat
NCT02290106 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Pitavastatin on Insulin Sensitivity and Liver Fat
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 2, 2015
- Completion date
- April 30, 2018
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fatty liver, nonalcoholic, obesity